nts respond to immune checkpoint treatments. Dr. Watson presented his team's findings at the 2017 Cancer Trials Group Annual Spring Meeting, at the Cancer Research Program Research Institute of the McGill University Health Center and at the Lady Davis Institute Seminar Series at Jewish General Hospital in Montreal. We appreciate your on